Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Showing 20 of 0 results

Not applicableStudy completedNCT04930640
What this trial is testing

The Efficacy and Safety of SGF200 on Immune Enhancement

Who this might be right for
Immunity
Chonbuk National University Hospital 100
Early research (Phase 1)Study completedNCT01343303
What this trial is testing

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis

Who this might be right for
Osteoarthritis, Knee
Janssen Research & Development, LLC 43
Not applicableStudy completedNCT07547761
What this trial is testing

A Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults

Who this might be right for
Body Odor
Kingdom 5
Large-scale testing (Phase 3)Study completedNCT02504489
What this trial is testing

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
BeyondSpring Pharmaceuticals Inc. 559
Early research (Phase 1)WithdrawnNCT03058068
What this trial is testing

Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Joshua M Hare
Testing effectiveness (Phase 2)Study completedNCT01769274
What this trial is testing

Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia

Who this might be right for
Inherited Erythromelalgia
Pfizer 5
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Post-approval studies (Phase 4)Study completedNCT04400318
What this trial is testing

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

Who this might be right for
Asthma
Sanofi 109
Testing effectiveness (Phase 2)UnknownNCT00604760
What this trial is testing

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Memory Pharmaceuticals 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT05896124
What this trial is testing

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Who this might be right for
Primary Biliary Cholangitis (PBC)
Cascade Pharmaceuticals, Inc 75
Testing effectiveness (Phase 2)Study completedNCT01448850
What this trial is testing

Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
MedImmune LLC 464
Early research (Phase 1)Study completedNCT07629310
What this trial is testing

To Evaluate the Safety of JL18008

Who this might be right for
HIV Infections
Jecho Biopharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT01837420
What this trial is testing

Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Who this might be right for
Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 194
Early research (Phase 1)Study completedNCT00840320
What this trial is testing

Repeat Dose Safety Study for Compound to Treat Anemia

Who this might be right for
Kidney Disease
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Ended earlyNCT00773890
What this trial is testing

TRF-1101 Assessment in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
TRF Pharma, Inc 80
Early research (Phase 1)Study completedNCT03001297
What this trial is testing

Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

Who this might be right for
Healthy Volunteers
MedImmune LLC 64
Large-scale testing (Phase 3)Ended earlyNCT01609582
What this trial is testing

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Who this might be right for
Type 2 DiabetesCardiovascular Disease
Takeda 3,207
Testing effectiveness (Phase 2)Looking for participantsNCT07216027
What this trial is testing

Learn About Study Medicine Called PF-08049820 in People With Eczema

Who this might be right for
Atopic DermatitisEczema, Atopic
Pfizer 165
Large-scale testing (Phase 3)Ended earlyNCT05011513
What this trial is testing

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Who this might be right for
COVID-19
Pfizer 1,440
Large-scale testing (Phase 3)UnknownNCT02263924
What this trial is testing

Stroke and Tocotrienol: Unique Role in Neuroprotection

Who this might be right for
Ischemic Stroke
Seberang Jaya Clinical Research Centre 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation